Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Odessa
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Odessa, TX

Studies commonly pay $75 to $4,500 per completed study

18 clinical trials are currently recruiting participants within 30 miles of Odessa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

18studies recruiting
3+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Odessa right now

Top 19 of 18 recruiting studies, sorted by proximity — each links to its official registry page

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Phase 3 Interventional 1,410 participants sought
Texas Oncology - West Texas — Odessa, Texas (2.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222566)

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Cardiovascular Disease Phase 3 Interventional 15,100 participants sought
Research Site — Odessa, Texas (2.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07000357)

Validating Dozee for Contactless Monitoring of Heart, Breathing, and Movemen

No Specific Medical Conditions or Disease States, No Specific Conditions N/A Observational 60 participants sought
ERA Health Research — Midland, Texas (17.6 mi) · Sponsor: Turtle Shell Technologies Pvt. Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07223931)

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung Phase 2 Interventional 480 participants sought
Texas Oncology Odessa-West Texas Cancer Center — Odessa, Texas (2.7 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06667076)

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 10,450 participants sought
ERA Health Research-Texas — Midland, Texas (17.6 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07157774)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigative Site 1024 — Odessa, Texas (2.7 mi) · Sponsor: Anthos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05712200)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Odessa, Texas (2.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
Texas Oncology - West Texas — Odessa, Texas (2.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222800)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Texas Oncology-West Texas — Odessa, Texas (2.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07144280)

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

Atrial Fibrillation (AF) Phase 3 Interventional 15,364 participants sought
Permian Research Foundation — Odessa, Texas (2.7 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07626411)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Odessa, Texas (2.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06129864)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Midland, Texas (17.6 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Small-cell Lung Cancer Phase 3 Interventional 480 participants sought
Zai Lab Site 02025 — Odessa, Texas (2.7 mi) · Sponsor: Zai Lab (Shanghai) Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07218146)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
USOR - Texas Oncology - Dallas Fort Worth (DFW) - Odessa West Texas Cancer Center — Odessa, Texas (2.7 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04613596)

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Heart Failure and Impaired Kidney Function Phase 3 Interventional 4,800 participants sought
Research Site — Odessa, Texas (2.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06307652)

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Atrial Fibrillation (AF) Phase 2 Interventional 1,200 participants sought
Permian Research Foundation — Odessa, Texas (2.7 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07175428)

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

IgA Nephropathy Phase 4 Interventional 60 participants sought
Permian Basin Kidney Center — Odessa, Texas (2.7 mi) · Sponsor: Calliditas Therapeutics AB
See eligibility & contact on ClinicalTrials.gov (NCT06712407)
Actively enrolling

Studies you may be able to join near Odessa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Odessa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Permian Research

315 E 5th St, Odessa, TX 79761
(432) 368-6950

ERA Health Research - Midland, TX

★ 5.0 (4 reviews)
3401 Greenbriar Dr #200, Midland, TX 79707
(432) 243-3886
"Staff is friendly and knowledgeable. Great way to improve new medical treatments."
— Haley Mecham, 5★

Abundance Regenerative Health Clinic

★ 5.0 (10 reviews)
Apex Center Building, 15 Smith Rd, Midland, TX 79705
(432) 219-8092

Clinical trials in Odessa: what's recruiting

The Odessa area currently has 18 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Odessa, the most active research areas are:

  • Cancer & Oncology8 studies
  • Heart & Vascular3 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Odessa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Odessa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Odessa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Odessa?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Odessa, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Odessa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Odessa?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Odessa.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Odessa typically complete one or two studies per year.

Paid clinical trials near Odessa

Other metros within reach

Midland, TX18 Lubbock, TX105 Amarillo, TX96 El Paso, TX187 Las Cruces, NM15 San Antonio, TX1,023 Killeen, TX105 Austin, TX736

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Odessa Bladder Issues Due To Spinal Cord Injury in Odessa All conditions

More of TX

Houston3,068 Pasadena3,007 Irving1,979 Grand Prairie1,947 Arlington1,866 Dallas1,864 Garland1,826 Plano1,817 Frisco1,816 Mesquite1,767 San Antonio1,023 Austin736

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts